- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Evolving strategies for addressing CAR T-cell toxicities ; volume:44 ; number:1 ; day:15 ; month:12 ; year:2024 ; pages:1-29 ; date:3.2025
Cancer and metastasis reviews ; 44, Heft 1 (15.12.2024), 1-29, 3.2025
- Creator
-
Rankin, Alexander W.
Duncan, Brynn B.
Allen, Cecily
Silbert, Sara K.
Shah, Nirali N.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10555-024-10227-1
- URN
-
urn:nbn:de:101:1-2502262121071.441567760120
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rankin, Alexander W.
- Duncan, Brynn B.
- Allen, Cecily
- Silbert, Sara K.
- Shah, Nirali N.
- SpringerLink (Online service)
Other Objects (12)
New insights into CAR T-cell hematological toxicities: manifestations, mechanisms, and effective management strategies
CAR T-Cell therapy
Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities
Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy
Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy
The CAR T‐Cell Mechanoimmunology at a Glance
Axicabtagene Ciloleucel CAR T-cell therapy for relapsed/refractory secondary CNS non-Hodgkin lymphoma: comparable outcomes and toxicities, but shorter remissions may warrant alternative consolidative strategies?
The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic
CAR T-cell therapy in diffuse large B-cell lymphoma
Hepatitis B virus reactivation associated with CAR T-cell therapy
Advances in CAR-T-cell therapy in T-cell malignancies
Fueling CARs: metabolic strategies to enhance CAR T-cell therapy
New insights into CAR T-cell hematological toxicities: manifestations, mechanisms, and effective management strategies
CAR T-Cell therapy
Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities
Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy
Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy
The CAR T‐Cell Mechanoimmunology at a Glance
Axicabtagene Ciloleucel CAR T-cell therapy for relapsed/refractory secondary CNS non-Hodgkin lymphoma: comparable outcomes and toxicities, but shorter remissions may warrant alternative consolidative strategies?
The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic
CAR T-cell therapy in diffuse large B-cell lymphoma
Hepatitis B virus reactivation associated with CAR T-cell therapy
Advances in CAR-T-cell therapy in T-cell malignancies
Fueling CARs: metabolic strategies to enhance CAR T-cell therapy
New insights into CAR T-cell hematological toxicities: manifestations, mechanisms, and effective management strategies
CAR T-Cell therapy
Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities
Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy
Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy
The CAR T‐Cell Mechanoimmunology at a Glance
Axicabtagene Ciloleucel CAR T-cell therapy for relapsed/refractory secondary CNS non-Hodgkin lymphoma: comparable outcomes and toxicities, but shorter remissions may warrant alternative consolidative strategies?
The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic
CAR T-cell therapy in diffuse large B-cell lymphoma
Hepatitis B virus reactivation associated with CAR T-cell therapy
Advances in CAR-T-cell therapy in T-cell malignancies